
Terumo Aortic
Committed to Aortic Care. Together with our customers, we strive to create effective management of aortic disease and drive the evolution of our cardiovascular solutions for our patients.
This is the official VuMedi channel of Terumo Aortic. It is only intended for medical professionals and is not a substitute for ...
read more ↘ medical advice nor promotion of any medical procedure or product. Please be advised that not all of our products shown on this channel are registered in, approved for sale in, or available for purchase in, all countries or regions where this channel is accessible.
↖ read less
This is the official VuMedi channel of Terumo Aortic. It is only intended for medical professionals and is not a substitute for ...
read more ↘ medical advice nor promotion of any medical procedure or product. Please be advised that not all of our products shown on this channel are registered in, approved for sale in, or available for purchase in, all countries or regions where this channel is accessible.
↖ read less
Video Player is loading.
Current Time 0:00
/
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time -0:00
1x
- 0.5x
- 0.75x
- 1x, selected
- 1.25x
- 1.5x
- 1.75x
- 2x
- Chapters
- descriptions off, selected
- captions settings, opens captions settings dialog
- captions off, selected
This is a modal window.
Beginning of dialog window. Escape will cancel and close the window.
End of dialog window.
10 seconds
Playback speed
This is a modal window. This modal can be closed by pressing the Escape key or activating the close button.
TREO® Stent-Graft System: IDE Data Webinar
110 views
April 7, 2021
In this video, Dr. Eagleton talks about TREO AAA stent graft system and its US ...
read more ↘ pivotal study results. The study done on 150 patients showed high rates of successful aneurysm treatment with more than 50% treated patients reporting >5 mm sac shrinkage at 3 years follow up
↖ read less
read more ↘ pivotal study results. The study done on 150 patients showed high rates of successful aneurysm treatment with more than 50% treated patients reporting >5 mm sac shrinkage at 3 years follow up
↖ read less
The content, discussion and opinions expressed in this video are those of the physician and may not be reflective of the approved indications for use of the device, which may also differ by region. Please consult eifu.terumoaortic.com for product indications, contraindications and warnings/precautions.
Comments are disabled for this content.
Endovascular
Wed, Feb 9, 2022
Faculty: Piotr Szopiński , Martin Funovics , Bartosz Rylski , Robin Heijmen , Terumo Aortic
Faculty: Piotr Szopiński , Martin Funovics , Bartosz Rylski , Robin Heijmen , Terumo Aortic